Literature DB >> 15169897

Activation of a DNA damage checkpoint response in a TAF1-defective cell line.

Ann M Buchmann1, Jeffrey R Skaar, James A DeCaprio.   

Abstract

Although the link between transcription and DNA repair is well established, defects in the core transcriptional complex itself have not been shown to elicit a DNA damage response. Here we show that a cell line with a temperature-sensitive defect in TBP-associated factor 1 (TAF1), a component of the TFIID general transcription complex, exhibits hallmarks of an ATR-mediated DNA damage response. Upon inactivation of TAF1, ATR rapidly localized to subnuclear foci and contributed to the phosphorylation of several downstream targets, including p53 and Chk1, resulting in cell cycle arrest. The increase in p53 expression and the G(1) phase arrest could be blocked by caffeine, an inhibitor of ATR. In addition, dominant negative forms of ATR but not ATM were able to override the arrest in G(1). These results suggest that a defect in TAF1 can elicit a DNA damage response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15169897      PMCID: PMC419897          DOI: 10.1128/MCB.24.12.5332-5339.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  Requirement for TAF(II)250 acetyltransferase activity in cell cycle progression.

Authors:  E L Dunphy; T Johnson; S S Auerbach; E H Wang
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK.

Authors:  C A Hall-Jackson; D A Cross; N Morrice; C Smythe
Journal:  Oncogene       Date:  1999-11-18       Impact factor: 9.867

3.  A role for ATR in the DNA damage-induced phosphorylation of p53.

Authors:  R S Tibbetts; K M Brumbaugh; J M Williams; J N Sarkaria; W A Cliby; S Y Shieh; Y Taya; C Prives; R T Abraham
Journal:  Genes Dev       Date:  1999-01-15       Impact factor: 11.361

4.  Caffeine inhibits the checkpoint kinase ATM.

Authors:  A Blasina; B D Price; G A Turenne; C H McGowan
Journal:  Curr Biol       Date:  1999-10-07       Impact factor: 10.834

5.  A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage.

Authors:  T T Paull; E P Rogakou; V Yamazaki; C U Kirchgessner; M Gellert; W M Bonner
Journal:  Curr Biol       Date:  2000 Jul 27-Aug 10       Impact factor: 10.834

6.  Different functional domains of TAFII250 modulate expression of distinct subsets of mammalian genes.

Authors:  T O'Brien; R Tjian
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

7.  Defect in the p53-Mdm2 autoregulatory loop resulting from inactivation of TAF(II)250 in cell cycle mutant tsBN462 cells.

Authors:  C Wasylyk; B Wasylyk
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

8.  The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.

Authors:  S Y Shieh; J Ahn; K Tamai; Y Taya; C Prives
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

9.  Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.

Authors:  Q Liu; S Guntuku; X S Cui; S Matsuoka; D Cortez; K Tamai; G Luo; S Carattini-Rivera; F DeMayo; A Bradley; L A Donehower; S J Elledge
Journal:  Genes Dev       Date:  2000-06-15       Impact factor: 11.361

10.  Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.

Authors:  R S Tibbetts; D Cortez; K M Brumbaugh; R Scully; D Livingston; S J Elledge; R T Abraham
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

View more
  13 in total

1.  Transcription factor TAFII250 phosphorylates the acidic domain of Mdm2 through recruitment of protein kinase CK2.

Authors:  Nerea Allende-Vega; Lynsey McKenzie; David Meek
Journal:  Mol Cell Biochem       Date:  2008-06-12       Impact factor: 3.396

Review 2.  ATR: an essential regulator of genome integrity.

Authors:  Karlene A Cimprich; David Cortez
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07-02       Impact factor: 94.444

3.  Caffeine inhibits human immunodeficiency virus type 1 transduction of nondividing cells.

Authors:  René Daniel; Elena Marusich; Elias Argyris; Richard Y Zhao; Anna Marie Skalka; Roger J Pomerantz
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

Review 4.  Emerging common molecular pathways for primary dystonia.

Authors:  Mark S Ledoux; William T Dauer; Thomas T Warner
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

5.  Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53.

Authors:  N Allende-Vega; M K Saville; D W Meek
Journal:  Oncogene       Date:  2007-01-22       Impact factor: 9.867

Review 6.  Bromodomains as therapeutic targets.

Authors:  Susanne Muller; Panagis Filippakopoulos; Stefan Knapp
Journal:  Expert Rev Mol Med       Date:  2011-09-13       Impact factor: 5.600

7.  Arabidopsis TAF1 is an MRE11-interacting protein required for resistance to genotoxic stress and viability of the male gametophyte.

Authors:  Wanda M Waterworth; Georgina E Drury; George Blundell-Hunter; Christopher E West
Journal:  Plant J       Date:  2015-10-08       Impact factor: 6.417

8.  INTS3 controls the hSSB1-mediated DNA damage response.

Authors:  Jeffrey R Skaar; Derek J Richard; Anita Saraf; Alfredo Toschi; Emma Bolderson; Laurence Florens; Michael P Washburn; Kum Kum Khanna; Michele Pagano
Journal:  J Cell Biol       Date:  2009-09-28       Impact factor: 10.539

Review 9.  Targeting TBP-Associated Factors in Ovarian Cancer.

Authors:  Jennifer R Ribeiro; Lindsay A Lovasco; Barbara C Vanderhyden; Richard N Freiman
Journal:  Front Oncol       Date:  2014-03-11       Impact factor: 6.244

10.  Biased multicomponent reactions to develop novel bromodomain inhibitors.

Authors:  Michael R McKeown; Daniel L Shaw; Harry Fu; Shuai Liu; Xiang Xu; Jason J Marineau; Yibo Huang; Xiaofeng Zhang; Dennis L Buckley; Asha Kadam; Zijuan Zhang; Stephen C Blacklow; Jun Qi; Wei Zhang; James E Bradner
Journal:  J Med Chem       Date:  2014-10-31       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.